CLOSE
Growing up in the small town of Ludowici, Georgia, all Dustin McGowan ever wanted to do was play baseball. The last thing he expected was a type 1 diabetes diagnosis that came when
Type
Type 1 diabetes could develop when babies are still in the WOMB
![a close up of a hand holding a remote control: MailOnline logo](https://www.msn.com/{"default":{"load":"default","w":"80","h":"48","src":"//img-s-msn-com.akamaized.net/tenant/amp/entityid/BB19QSgS.img?h=480&w=799&m=6&q=60&o=f&l=f"},"size3column":{"load":"default","w":"62","h":"38","src":"//img-s-msn-com.akamaized.net/tenant/amp/entityid/BB19QSgS.img?h=375&w=624&m=6&q=60&o=f&l=f"},"size2column":{"load":"default","w":"62","h":"38","src":"//img-s-msn-com.akamaized.net/tenant/amp/entityid/BB19QSgS.img?h=375&w=624&m=6&q=60&o=f&l=f"}})
© Provided by Daily Mail
MailOnline logo
Type 1 diabetes may develop when babies are still in the womb, a study has found.
Previously experts thought that the condition only strikes when infants are older than six months.
But new research led by the University of Exeter found that the autoimmune disease – which occurs when the immune system attacks insulin-producing cells- can develop before infants are even born.
Experts
Regenerative Medicine Market Remarkable Impact on Advancement, Size, Type and Share|Organogenesis Inc, Osiris Therapeutics Inc, Pfizer Inc
Pune, Maharashtra, India, September 28 2020 (Wiredrelease) MarketResearch.Biz –:The recent report posted via MarketResearch.Biz on Regenerative Medicine market offers critical market insights in conjunction with targeted segmentation evaluation. The report examines key using elements which might be anticipated to drive the increase of the market.
Global Regenerative Medicine Market Research Report offers crucial data on numerous market situations, for example, ability improvement elements, elements controlling the advancement, market possibilities, and
New Procedure May Eliminate Need for Insulin with Type 2 Diabetes
- A new procedure could help eliminate the need for insulin for some people with type 2 diabetes.
- The results of a clinical trial involving the new technique were unveiled today at a conference.
- The outpatient procedure involves inserting
Could Type 1 Diabetes Begin in Utero?
Infants might develop type 1 diabetes in the first 6 months of life and seems to be unrelated to known genetic risk factors; rather, it appears linked to low birth weight, say UK researchers.
They believe the discovery could mean the disease starts in utero.
Others are skeptical, however.
The team studied 166 infants with diabetes diagnosed before 6 months of age and compared them to babies with the more
Regular use of acid reflux drugs linked to heightened risk of type 2 diabetes
Regular use of acid reflux drugs, known as proton pump inhibitors, or PPIs for short, is linked to a heightened risk of developing type 2 diabetes, finds research published online in the journal Gut.
And the longer these drugs are taken, the greater the risk seems to be, the findings show, prompting the researchers to advise that people taking these drugs for 2 or more
Diabetes type 2 symptoms: High blood sugar signs on your skin include having a dark patch
Diabetes is a common condition that affects more than four million people in the UK, and 90 percent of all cases are caused by type 2 diabetes. You could be at risk of high blood sugar if you find an unusual dark patch of skin on your body, it’s been claimed.
Type 2 diabetes could be caused by the body not producing enough of the hormone insulin, or the body
Research finds type 1 diabetes develops in infants
Babies under six months can develop type 1 diabetes, and the condition may begin to take root before they are born, according to scientists.
It was previously thought infants who are less than six months old could only develop neonatal diabetes – which is caused by a genetic mutation that affects the pancreas cells which produce insulin.
But researchers now believe younger babies can also develop type 1 diabetes, a
Hearing Loss with Type 1 Diabetes? What to Know
True confession: I have hearing loss. Significant enough that my audiology doctor prescribed hearing aids, a prescription that I never filled. Like most people, hearing aids aren’t covered by my health insurance, and, again like most people, I can’t afford them out of pocket. But that’s a story for another day.
As to the hearing loss itself, I had always thought it was the result of indiscretions of my youth:
Emerging Data on Type 1 Diabetes and COVID-19 Reassuring
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center.
Most people with type 1 diabetes do not appear to be at increased risk for hospitalization or death from COVID-19 compared to the general population, new research suggests.
Two retrospective studies of type 1 diabetes and COVID-19 were published in the October issue of Diabetes Care.
One, by Roman Vangoitsenhoven, MD, PhD, of University Hospitals
Type 2 diabetes symptoms: Passing large amounts of urine could be a sign
Type 2 diabetes is a common condition that causes a person’s blood sugar (glucose) levels to become too high, and left untreated, serious complications can occur including cardiovascular disease, nerve damage and kidney damage.
One of the symptoms of type 2 diabetes may appear when you go to the toilet, according to Patient.info – passing large amounts of urine.
The health site explains: “The reason why you make a lot
Screening UK Biobank blood samples identifies thousands of undiagnosed cases of type 2 diabetes
A study of approximately 200,000 blood samples from the UK Biobank has identified more than 2,000 undiagnosed cases of type 2 diabetes. The study, presented at this year’s Annual Meeting of the European Association for the Study of Diabetes (EASD), also shows that, because UK Biobank data is not reported back to participants, patients found to have undiagnosed diabetes waited on average more than two years for a clinical diagnosis,
‘Couple-focused’ strategies may help prevent type 2 diabetes development
September 23, 2020
2 min read
Source/Disclosures
Source:
Silverman-Retana O, et al. Abstract #332. Presented at: EASD Annual Meeting; Sept. 21-25, 2020 (virtual meeting).
Disclosures:
Silverman-Retana reports he has received support from the Danish Diabetes Academy, the Danish Diabetes Association, the EFSD Albert Renold Travel Fellowship Programme and the Steno Diabetes Center Aarhus.
Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes
Trial Design and Oversight
This multicenter, double-blind, randomized, placebo-controlled, event-driven, noninferiority trial involved patients with type 2 diabetes and established atherosclerotic cardiovascular disease.12 The protocol (available with the full text of this article at NEJM.org) was approved by the relevant regulatory authorities and ethics committees responsible for each trial site.
In collaboration with a group of academic investigators who comprised the scientific advisory committee, representatives of the sponsors (Merck
Loneliness Could be Linked to Type 2 Diabetes
People with diabetes are at a greater risk of dying from COVID-19, according to results. Prolonged loneliness may influence the development of diabetes. Lockdown during the pandemic could compound people’s vulnerability if the loneliness continues.
A fifth of adults in the UK and a third of adults in the USA report feeling lonely sometimes.
Previous research has associated loneliness with an increased risk of death and heart disease.
The study
Novel Type 2 Diabetes Drugs Incur High Costs in Medicare
Switching Medicare beneficiaries who have type 2 diabetes to one of the novel glucose-lowering medications could dramatically raise their out-of-pocket costs, thereby potentially hindering adherence, new research suggests.
The researchers examined price and cost-sharing data for six classes of glucose-lowering drugs in a total of 3323 stand-alone and Medicare Advantage Part D plans.
Out-of-pocket costs for the novel glucose-lowering drugs ― sodium-glucose cotransporter-2 (SGLT2) inhibitors, glucagon-like peptide-1 (GLP-1) agonists, and
New study identifies more than 2,000 undiagnosed cases of type 2 diabetes
A study of approximately 200,000 blood samples from the UK Biobank has identified more than 2,000 undiagnosed cases of type 2 diabetes.
The study, presented at this year’s Annual Meeting of the European Association for the Study of Diabetes (EASD), also shows that, because UK Biobank data is not reported back to participants, patients found to have undiagnosed diabetes waited on average
Trial Holds Promise for Weekly Insulin for Type 2
By Serena Gordon
HealthDay Reporter
TUESDAY, Sept. 22, 2020 (HealthDay News) — Type 2 diabetes can be tough to control without medication. But for some people, the thought of daily shots makes them delay or avoid starting insulin therapy.
Now, new research offers some hope for those insulin avoiders — a once-a-week insulin injection may someday replace daily shots.
A phase 2 trial compared the new weekly
Study suggests heightened risk of dementia in individuals with type 2 diabetes varies by type of dementia
It is well known that having type 2 diabetes is associated with an increased risk of dementia, but a large observational study comparing over 370,000 people with type 2 diabetes with nearly 2 million matched controls over an average of 7 years, now suggests that the risk is highest for vascular dementia and among individuals with poor blood sugar control.
The findings, being presented at The
Once-a-week insulin for type 2 diabetes shows promise in early trial
(HealthDay)—Type 2 diabetes can be tough to control without medication. But for some people, the thought of daily shots makes them delay or avoid starting insulin therapy.
Now, new research offers some hope for those insulin avoiders—a once-a-week insulin injection may someday replace daily shots.
A phase 2 trial compared the new weekly insulin, called icodec, to the commonly used insulin glargine (Lantus, Basaglar), and found the new insulin led